Macular oedema in central retinal vein occlusion treated with intravitreal triamcinolone

Acta Ophthalmologica Scandinavica

Volumn 84, Issue 3, 2006, Pages 314-318

  Gelston, Christopher D ^a   Olson, Jeffrey L ^a   Mandava, Naresh ^a  

^a UNIVERSITY OF COLORADO SCHOOL OF MEDICINE   (United States)

Author keywords

Central retinal vein occlusion; Intraocular pressure; Intravitreal triamcinolone; Macular oedema

Indexed keywords

TRIAMCINOLONE ACETONIDE;

ADULT; AGED; ARTICLE; CASE STUDY; CENTRAL RETINA VEIN OCCLUSION; CLINICAL ARTICLE; COMPARATIVE STUDY; CONTROLLED STUDY; DATA ANALYSIS; DRUG EFFICACY; FEMALE; HUMAN; INTRAOCULAR PRESSURE; MALE; POSTOPERATIVE PERIOD; PRIORITY JOURNAL; RETINA ISCHEMIA; RETINA MACULA EDEMA; RETROSPECTIVE STUDY; STATISTICAL ANALYSIS; STATISTICAL SIGNIFICANCE; VISUAL ACUITY; VISUAL SYSTEM EXAMINATION;

ADULT; AGED; AGED, 80 AND OVER; FEMALE; GLUCOCORTICOIDS; HUMANS; INJECTIONS; INTRAOCULAR PRESSURE; ISCHEMIA; MACULAR EDEMA, CYSTOID; MALE; MIDDLE AGED; RETINAL VEIN OCCLUSION; RETROSPECTIVE STUDIES; TREATMENT OUTCOME; TRIAMCINOLONE ACETONIDE; VISUAL ACUITY; VITREOUS BODY;

EID: 33646807793     PISSN: 13953907     EISSN: 16000420     Source Type: Journal    
DOI: 10.1111/j.1600-0420.2005.00605.x     Document Type: Article

References (18)

1. Antcliff RJ, Spalton DJ, Stanford MR, Graham EM, Ffytche TJ & Marshal J (2001): Intravitreal triamcinolone for uveitic cystoid macular oedema: An optical coherence tomography study. Ophthalmology 108: 765-772.
2. Bashshur ZF, Ma'luf RN, Allam S, Jurdi FA, Haddad RS & Noureddin BN (2004): Intravitreal triamcinolone for the management of macular oedema due to non-ischaemic central retinal vein occlusion. Arch Ophthalmol 122: 1137-1140.
3. Central Retinal Vein Occlusion Study Group (1995): Evaluation of grid pattern photocoagulation for macular oedema in central retinal vein occlusion. The Central Retinal Vein Occlusion Study Group M Report. Ophthalmology 102: 1425-1433.
4. Central Retinal Vein Occlusion Study Group (1997): Natural history and clinical management of central retinal vein occlusion. Arch Ophthalmol 115: 486-491.
5. Edelman JL, Lutz D & Castro MR (2005): Corticosteroids inhibit VEGF-induced vascular leakage in a rabbit model of blood-retinal and blood-aqueous barrier breakdown. Exp Eye Res 80: 249-258.
6. Gass JDM (1997): Macular dysfunction caused by retinal vascular disease. In: Gass JDM (ed). Stereoscopic Atlas of Macular Diseases. 4th edn. St. Louis, Missouri: Mosby 437-599.
7. Ghazi NG, Noureddine B, Haddad RS, Jurdi FA & Bashshur ZF (2003): Intravitreal tissue plasminogen activator in the management of central retinal vein occlusion. Retina 23: 780-784.
8. Glacet-Bernard A, Coscas G, Chabanel A, Zourdani A, Lelong F & Samama MM (1996): Prognostic factors for retinal vein occlusion: prospective study of 175 cases. Ophthalmology 103: 551-560.
9. Green WR, Chan CC, Hutchins GM & Terry JM (1981): Central retinal vein occlusion: A prospective histopathologic study of 29 eyes in 28 cases. Retina 1: 27-55.
10. Ip MS, Gottlieb JL, Kahana A et al. (2004): Intravitreal triamcinolone for the treatment of macular oedema associated with central retinal vein occlusion. Arch Ophthalmol 122: 1131-1136.
11. Ip M, Kahana A & Altaweel M (2003): Treatment of central retinal vein occlusion with triamcinolone acetonide: An optical coherence tomography study. Semin Ophthalmol 18: 67-73.
12. Jonas JB, Kreissig I, Söfker A & Degenring RF (2003): Intravitreal injection of triamcinolone for diffuse diabetic macular oedema. Arch Ophthalmol 121: 57-61.
13. Martidis A, Duker JS, Greenberg PB et al. (2002): Intravitreal triamcinolone for refractory diabetic macular oedema. Ophthal-mology 109: 920-927.
14. Miyake K, Miyake T & Kayazawa F (1992): Blood-aqueous barrier in eyes with retinal vein occlusion. Ophthalmology 99: 906-910.
15. Nauck M, Karakiulakis G, Perruchoud AP, Papakonstantinou E & Roth M (1998): Corticosteroids inhibit the expression of the vascular endothelial growth factor gene in human vascular smooth muscle cells. Eur J Pharmacol 341: 309-315.
16. Qaum T, Xu Q, Joussen AM et al. (2001): VEGF-initiated blood-retinal barrier breakdown in early diabetes. Invest Ophthalmol Vis Sci 42: 2408-2413.
17. Smithen LM, Ober MD, Maranan L & Spaide RF (2004): Intravitreal triamcinolone acetonide and intraocular pressure. Am J Ophthalmol 138: 740-743.
18. Weizer JS, Stinnett SS & Fekrat S (2003): Radial optic neurotomy as treatment for central retinal vein occlusion. Am J Ophthalmol 136: 814-819.